PAPER Luengnaruemitchai G, Sangchocanonta S, Munthuli A, Phienphanich P, Puangarom S, Jariyakosol S, Hirunwiwatkul P, Tantibundhit C

Automated Alzheimer's, Mild Cognitive Impairment, and Normal Aging Screening using Polar Transformation of Optic Disc and Central Zone of Fundus Images.

Annu Int Conf IEEE Eng Med Biol Soc. 2024 Jul;2024:1-4. PubMed.

PAPER Elliott C

A scientific field, misledDoctored: Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer's Charles Piller Atria/One Signal, 2025. 352 pp.

Science. 2025 Feb 14;387(6735):724. Epub 2025 Feb 13 PubMed.

PAPER Coughlan GT, Rubinstein Z, Klinger H, Lopez KA, Hsieh S, Boyle R, Seto M, Townsend D, Mayblyum D, Thibault E, Jacobs HI, Farrell M, Rabin JS, Papp K, Amariglio R, Baker S, Lois C, Rentz D, Price J, Schultz A, Properzi M, Johnson K, Sperling R, Buckley RF

Associations between hormone therapy use and tau accumulation in brain regions vulnerable to Alzheimer's disease.

Sci Adv. 2025 Mar 7;11(10):eadt1288. Epub 2025 Mar 5 PubMed.

PAPER Wood Alexander M, Honer WG, Saloner R, Galea LA, Bennett DA, Rabin JS, Casaletto KB

The interplay between age at menopause and synaptic integrity on Alzheimer's disease risk in women.

Sci Adv. 2025 Mar 7;11(10):eadt0757. Epub 2025 Mar 5 PubMed.

PAPER Bonkhoff AK, Coughlan G, Perosa V, Alhadid K, Schirmer MD, Regenhardt RW, van Veluw S, Buckley R, Fox MD, Rost NS

Sex differences in age-associated neurological diseases-A roadmap for reliable and high-yield research.

Sci Adv. 2025 Mar 7;11(10):eadt9243. Epub 2025 Mar 5 PubMed.

PAPER Aguzzoli Heberle B, Fox KL, Lobraico Libermann L, Ronchetti Martins Xavier S, Tarnowski Dallarosa G, Carolina Santos R, Fardo DW, Wendt Viola T, Ebbert MT

Systematic review and meta-analysis of bulk RNAseq studies in human Alzheimer's disease brain tissue.

Alzheimers Dement. 2025 Mar;21(3):e70025. PubMed.

PAPER Ono D, Sekiya H, Maier AR, Murray ME, Koga S, Dickson DW

Parkinsonism in Alzheimer's disease without Lewy bodies in association with nigral neuron loss: A data-driven clinicopathologic study.

Alzheimers Dement. 2025 Mar;21(3):e14628. PubMed.

PAPER Lee JK, Johnson L, Hall JR, Bateman JR, Barnes LL, O'Bryant S, Mielke MM

Chronic stress, social support, and Alzheimer's blood-based biomarkers in the HABS-HD study.

Alzheimers Dement. 2025 Mar;21(3):e70043. PubMed.

PAPER Ding H, Ye Z, Paschalidis A, Bennett DA, Au R, Lin H

Dynamic lifetime risk prediction of Alzheimer's disease with longitudinal cognitive assessment measurements.

Alzheimers Dement. 2025 Mar;21(3):e70055. PubMed.

PAPER Devanarayan V, Ye Y, Zhu L, Tian L, Kramer L, Irizarry M, Dhadda S

Predicted natural progression as an Alzheimer's prognostic covariate improves the precision of lecanemab efficacy assessments and clinical trial efficiency.

Alzheimers Dement. 2025 Mar;21(3):e70045. PubMed.

PAPER Mattke S, Yue S, Becker A, Liu Y

Demographic and clinical characteristics of initial patients receiving amyloid-targeting treatments in the United States after regulatory approval.

Alzheimers Dement. 2025 Mar;21(3):e70054. PubMed.

PAPER Sim MA, Tham YC, Nusinovici S, Quek TC, Yu M, Xue CC, Chee ML, Peng QS, Tan ES, Chan SP, Cai Y, Chong EJ, Tan BY, Venketasubramanian N, Hilal S, Lai MK, Choi H, Richards AM, Cheng CY, Chen CL

A deep-learning retinal aging biomarker for cognitive decline and incident dementia.

Alzheimers Dement. 2025 Mar;21(3):e14601. PubMed.

PAPER Lee SM, Yoon SJ, Park KW, Kim A, Kim HJ, Jung NY, Jang H, Seeley WW, Kim YE, Moon SY, Kim EJ, Longitudinal study of Early onset dementia And Family members (LEAF) investigators

Semantic variant primary progressive aphasia with ANXA11 p.D40G.

Alzheimers Dement. 2025 Mar;21(3):e14566. PubMed.

PAPER Shahidehpour RK, Nelson PT, Srinivasan S, Yu Z, Bachstetter AD

Assessing Co-Localization of ITM2B With Alzheimer's Disease and Limbic-Predominant Age-Related TDP-43 Encephalopathy Neuropathologic Changes.

Neuropathology. 2025 Mar 5; Epub 2025 Mar 5 PubMed.

PAPER Leuzy A, Bollack A, Pellegrino D, Teunissen CE, La Joie R, Rabinovici GD, Franzmeier N, Johnson K, Barkhof F, Shaw LM, Arkhipenko A, Schindler SE, Honig LS, Moscoso Rial A, Schöll M, Zetterberg H, Blennow K, Hansson O, Farrar G

Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease.

Alzheimers Dement. 2025 Mar;21(3):e14528. PubMed.